ici 118551 and Liver Neoplasms

ici 118551 has been researched along with Liver Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abraham, G; Guenl, B; Jonas, S; Kassahun, WT; Ungemach, FR1
Abraham, G; Günl, B; Hauss, J; Kassahun, WT; Tannapfel, A; Ungemach, FR1

Trials

1 trial(s) available for ici 118551 and Liver Neoplasms

ArticleYear
Alpha1-and beta2-adrenoceptors in the human liver with mass-forming intrahepatic cholangiocarcinoma: density and coupling to adenylate cyclase and phospholipase C.
    Naunyn-Schmiedeberg's archives of pharmacology, 2005, Volume: 372, Issue:3

    Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; CA-19-9 Antigen; Cholangiocarcinoma; Female; Humans; Liver Neoplasms; Male; Propanolamines; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-2; Type C Phospholipases

2005

Other Studies

1 other study(ies) available for ici 118551 and Liver Neoplasms

ArticleYear
Expression and functional coupling of liver β2 - adrenoceptors in the human hepatocellular carcinoma.
    Pharmacology, 2012, Volume: 89, Issue:5-6

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Carcinoma, Hepatocellular; Female; Humans; Imidazoles; Iodocyanopindolol; Liver; Liver Neoplasms; Male; Middle Aged; Propanolamines; Receptors, Adrenergic, beta-2

2012